GT Biopharma Stock Quote GTBP - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.72

Bid

2.71

Ask

2.76

Volume

9,879

2.69 Day's Range 2.87

2.60 52 Week Range 10.6599

Market Cap

3.896M

Previous Close

2.75

Open

2.69

Last Trade

100

2.72

Last Trade Time

12:44:49

Financial Volume

$ 27,444

VWAP

2.778

Average Volume (3m)

1,554,156

Shares Outstanding

1,416,651

Dividend Yield

PE Ratio

-0.51

Earnings Per Share (EPS)

-5.36

Revenue

Net Profit

-7.6M

GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cance... GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its key drug candidates are OXS-2175, targeting the treatment of triple-negative breast cancer; OXS-4235, targets the treatment of multiple myeloma and associated osteolytic lesions; and OXS-1550, targets cancer cells expressing the CD19 receptor and CD22 receptor. Its TriKE and TetraKE platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.gtbiopharma.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

GT Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GTBP. The last closing price for GT Biopharma was $2.75. Over the last year, GT Biopharma shares have traded in a share price range of $ 2.60 to $ 10.6599.

GT Biopharma currently has 1,416,651 shares outstanding. The market capitalization of GT Biopharma is $3.90 million. GT Biopharma has a price to earnings ratio (PE ratio) of -0.51.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.21	-7.16723549488	2.93	2.93	2.69	12960	2.76316954	CS
4	-0.24	-8.10810810811	2.96	3.74	2.6	54982	2.81925737	CS
12	-0.51	-15.7894736842	3.23	10.6599	2.6	1554156	7.16356425	CS
26	-4.33	-61.4184397163	7.05	10.6599	2.6	721160	7.11884994	CS
52	-5.725	-67.7915926584	8.445	10.6599	2.6	435919	7.21910898	CS
156	-368.323	-99.266931326	371.043	371.043	2.6	294388	48.42601675	CS
260	-162.28	-98.3515151515	165	591.993	2.6	329218	108.79836878	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MIRAMIRA Pharmaceuticals Inc	$ 2.7702 (302.18%)	116.72M
CMAXCareMax Inc	$ 4.67 (195.57%)	55.05M
SERVServe Robotics Inc	$ 10.739 (42.24%)	112.32M
NUKKNukkleus Inc	$ 0.43595 (36.23%)	12.73M
LPSNLivePerson Inc	$ 1.295 (30.81%)	4.33M
LGCBLinkage Global Inc	$ 3.64 (-30.20%)	122.08k
GSUNGolden Sun Health Technology Group Ltd	$ 4.93 (-26.64%)	125.69k
SLNASelina Hospitality PLC	$ 0.0354 (-25.16%)	49.98M
CGBSCrown LNG Holdings Ltd	$ 1.09 (-22.70%)	1.89M
TRNRInteractive Strength Inc	$ 0.7443 (-20.62%)	717.07k
NVDANVIDIA Corporation	$ 122.455 (3.84%)	139.37M
SQQQProShares UltraPro Short QQQ	$ 8.19 (-3.19%)	119.63M
MIRAMIRA Pharmaceuticals Inc	$ 2.7702 (302.18%)	116.72M
NCPLNetcapital Inc	$ 0.106 (1.92%)	113.06M
SERVServe Robotics Inc	$ 10.739 (42.24%)	112.32M